Company: ARTL
Filing Date: 2025-11-17
Form Type: S-1
Source: 0001640334-25-002154
Chunk: 32

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-17
Form: S-1
Chunk 32
---
orgas, (v) 400 shares of Common Stock held indirectly by Gorgas Family Trust and (vi) 49,328 shares of Common Stock issuable pursuant to options held directly by Gregory D. Gorgas exercisable within 60 days of November 10, 2025. |
| (2) | Consists of (i) 34,578 shares of Common Stock issuable upon conversion of the Notes, (ii) 38,346 shares of Common Stock issuable upon exercise of the $6.24 Warrants, (iii) 70,376 shares of Common Stock issuable upon exercise of the $3.40 Warrants, (iv) 6.30 shares held directly by Connie Matsui and (v) 3,340 shares of Common Stock issuable pursuant to options held directly by Connie Matsui exercisable within 60 days of November 10, 2025.                                                                                                 |

| 21 |

| (3) | Consists of (i) 139 shares held by Steven Kelly, and (ii) 3.207 shares of Common Stock issuable pursuant to options held directly by Steven Kelly exercisable within 60 days of November 10, 2025.                                                                                                                                                                                                           |
| (4) | Consists of (i) 139 shares held by Douglas Blayney, M.D., and (ii) 3,143 shares of Common Stock issuable pursuant to options held directly by Douglas Blayney, M.D. exercisable within 60 days of November 10, 2025.                                                                                                                                                                                         |
| (5) | Consists of (i) 139 shares held by R. Marty Emanuele, Ph.D., and (ii) 3,099 shares of Common Stock issuable pursuant to options held directly by R. Marty Emanuele, Ph.D. exercisable within 60 days of November 10, 2025.                                                                                                                                                                                   |
| (6) | Consists of 2,886 shares of Common Stock issuable pursuant to options held directly by Gregory R. Reyes M.D., Ph.D. exercisable within 60 days of November 10, 2025.                                                                                                                                                                                                                                         |
| (7) | Consists of (i) 6,174 shares of Common Stock issuable upon conversion of the Notes, (ii) 6,846 shares of Common Stock issuable upon exercise of the $6.24 Warrants, (iii) 12,566 shares of